State-of-the-art device speeds up pneumonia diagnosis

Community-acquired pneumonia (CAP), the most common type of pneumonia, is a leading cause of death globally with an associated annual cost in Europe of about EUR 10 billion. Current diagnostic methods are too slow, and increasing antibiotic resistance make CAP harder to treat.

CAP is the fourth most common cause of death in adults (90 % over 65) and the number one cause in children under 5. There are about 3.4 million cases reported annually in Europe. CAP is an enormous burden on the economy because of patients who are diagnosed too late. It also puts a tremendous strain on healthcare resources.

Further details: State-of-the-art device speeds up pneumonia diagnosis